title: Stripping out pus in lactational mastitis: a means of preventing breast abscess.
abstract: OBJECTIVE
  To determine whether manual stripping of pus from the breasts of women with lactational mastitis is effective in preventing the formation of breast abscesses.
  
  
  METHODS
  Case series (chart review).
  
  
  METHODS
  Family practice in Montreal.
  
  
  METHODS
  All (475) charts of patients with lactational mastitis were reviewed; 61 women were excluded because they already had a breast abscess. Most of the patients had been referred.
  
  
  METHODS
  Abscess formation, length of illness after treatment, rate of recurrence of mastitis, illness in the mother or infant within the 6 weeks after the mastitis and continuance of breast-feeding.
  
  
  RESULTS
  The duration of symptoms before treatment was 1 to 56 (mean 5.3) days. In 9% of the cases both breasts were affected, and in 23% at least one episode of mastitis had previously occurred. The stripping technique was applied to all the patients. Pus was removed in 210 women; the remaining women were considered to have cellulitis. Only four patients (less than 1%) had breast abscesses. The mean length of illness after treatment was 7.2 days. The rate of recurrence was 14%. In all, 6% of the mothers and 9% of the infants became ill in the 6 weeks after the mastitis. Most (92%) of the patients continued to breast-feed.
  
  
  CONCLUSIONS
  The rate of abscess formation was considerably lower than the rates reported in the literature. Therefore, manual stripping of pus from the infected breasts of lactating women appears to be effective in preventing breast abscesses.
authors.affiliation: University of Victoria, BC.
authors.forename: H
authors.initials: H
authors.lastname: Bertrand
authors.forename: L K
authors.initials: LK
authors.lastname: Rosenblood
mesh_terms: D000038:Abscess / Q000209:etiology / Q000517:prevention & control*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001941:Breast Diseases / Q000209:etiology / Q000517:prevention & control*; D003131:Combined Modality Therapy; D004322:Drainage / Q000379:methods*; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008199:Lymphadenitis / Q000150:complications / Q000628:therapy; D008413:Mastitis / Q000150:complications / Q000628:therapy*; D012008:Recurrence; D012189:Retrospective Studies; D012648:Self Care / Q000379:methods; D013492:Suppuration / Q000628:therapy
chemical_list: D000900:Anti-Bacterial Agents